Andere Sprachen Centessa Pharmaceuticals plc

Aktien

A3CQ72

US1523091007

CNTA

Biotechnologie

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 15.05.2026			% 5 Tage	Veränd. 1. Jan.
39.59 ^USD	-0.03%		0.00%	+58.30%

06.05.	Eli Lilly plant Anleiheemission über rund 8 Milliarden Dollar zur Finanzierung von Akquisitionen	MT
06.05.	Eli Lilly plant Anleiheemission über rund 8 Milliarden Dollar zur Finanzierung von Akquisitionen	MT

Andere Sprachen

11.05.	Centessa Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Centessa Pharmaceuticals plc - CNTA
06.05.	Eli Lilly Plans to Sell About $8 Billion of Bonds to Fund Acquisitions
06.05.	Eli Lilly Plans to Sell About $8 Billion of Bonds to Fund Acquisitions
05.05.	Centessa Pharmaceuticals plc Reports Earnings Results for the First Quarter Ended March 31, 2026
27.04.	Eli Lilly to Buy Ajax Therapeutics for Up to $2.3 Billion -- Update
20.04.	Eli Lilly to Strengthen Cancer Treatment Portfolio With $7 Billion Deal for Kelonia
20.04.	Eli Lilly to Buy Kelonia Therapeutics for Initial $3.25 Billion -- Update
07.04.	Gilead Sciences to Buy Clinical-Stage Biotech Tubulis for Up to $5 Billion -- Update
01.04.	Nxera Partner Centessa to Be Acquired by Lilly, Retains Royalty Rights
01.04.	Morning Meeting: Ahora el petróleo es vuestro problema
01.04.	PRESS DIGEST- New York Times business news - April 1
01.04.	Centessa Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Centessa Pharmaceuticals plc - CNTA
31.03.	Centessa Pharmaceuticals plc Reports Earnings Results for the Full Year Ended December 31, 2025
31.03.	Wall Street termine en hausse, rassurée par les propos de Washington et Téhéran
31.03.	Top Midday Gainers
31.03.	Eli Lilly to Acquire Centessa Pharmaceuticals in Deal Valued at Up to $7.8 Billion; Shares Rise
31.03.	Are APLS, CNTA, BIRD Obtaining Fair Deals for their Shareholders?
31.03.	Eli Lilly to Acquire Centessa Pharmaceuticals in Deal Valued at Up to $7.8 Billion
31.03.	Deals of the day-Mergers and acquisitions
31.03.	Trump maintient Téhéran sous pression et griffe ses alliés... Wall Street apprécie
31.03.	Wall Street ouvre en nette hausse, veut croire à une désescalade au Moyen-Orient
31.03.	Eli Lilly and Company entered into a definitive agreement to acquire Centessa Pharmaceuticals plc from a group of shareholders for $5.1 billion.
31.03.	Wall Street Weighs Signs Trump May End Iran War Even With Strait Shut, Driving Premarket Gains for Equity Futures
31.03.	Eli Lilly to Acquire Centessa Pharmaceuticals in Up to $7.8 Billion Deal
31.03.	Hausse attendue des indices américains avant le rapport JOLTS, le conflit au Moyen-Orient s'enlise